Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.

Byrne TJ, Rakela J.

World J Transplant. 2016 Jun 24;6(2):306-13. doi: 10.5500/wjt.v6.i2.306. Review.

2.

Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast-enhanced ultrasonography: Preliminary result.

Shiozawa K, Watanabe M, Ikehara T, Kogame M, Kikuchi Y, Igarashi Y, Sumino Y.

Oncol Lett. 2016 Jul;12(1):579-584. Epub 2016 Jun 1.

3.
4.

Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy.

Honda K, Seike M, Oribe J, Endo M, Arakawa M, Syo H, Iwao M, Tokoro M, Nishimura J, Mori T, Yamashita T, Fukuchi S, Muro T, Murakami K.

World J Hepatol. 2016 May 8;8(13):597-604. doi: 10.4254/wjh.v8.i13.597.

5.

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.

Lan T, Chang L, Mn R, Wu L, Yuan YF.

Medicine (Baltimore). 2016 Apr;95(15):e3185. doi: 10.1097/MD.0000000000003185.

6.

Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.

Potretzke TA, Ziemlewicz TJ, Hinshaw JL, Lubner MG, Wells SA, Brace CL, Agarwal P, Lee FT Jr.

J Vasc Interv Radiol. 2016 May;27(5):631-8. doi: 10.1016/j.jvir.2016.01.136. Epub 2016 Mar 24.

PMID:
27017124
7.

Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation.

Odisio BC, Richter M, Aloia TA, Conrad C, Ahrar K, Gupta S, Vauthey JN, Huang SY.

J Gastrointest Surg. 2016 Aug;20(8):1428-34. doi: 10.1007/s11605-016-3117-z. Epub 2016 Mar 16.

PMID:
26984694
8.

Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review.

He ZX, Xiang P, Gong JP, Cheng NS, Zhang W.

Ther Clin Risk Manag. 2016 Feb 23;12:295-303. doi: 10.2147/TCRM.S96760. eCollection 2016. Review.

9.

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.

Song MJ, Bae SH, Lee JS, Lee SW, Song do S, You CR, Choi JY, Yoon SK.

Korean J Intern Med. 2016 Mar;31(2):242-52. doi: 10.3904/kjim.2015.112. Epub 2016 Feb 15.

10.

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review.

Marin D, Cappabianca S, Serra N, Sica A, Lassandro F, D'Angelo R, La Porta M, Fiore F, Somma F.

Gastroenterol Res Pract. 2015;2015:670965. doi: 10.1155/2015/670965. Epub 2015 Dec 22. Review.

11.

Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.

Koh PS, Chan AC, Cheung TT, Chok KS, Dai WC, Poon RT, Lo CM.

HPB (Oxford). 2016 Jan;18(1):72-8. doi: 10.1016/j.hpb.2015.07.005.

12.
13.

Utilizing confocal laser endomicroscopy for evaluating the adequacy of laparoscopic liver ablation.

Schneider C, Johnson SP, Walker-Samuel S, Gurusamy K, Clarkson MJ, Thompson S, Song Y, Totz J, Cook RJ, Desjardins AE, Hawkes DJ, Davidson BR.

Lasers Surg Med. 2016 Mar;48(3):299-310. doi: 10.1002/lsm.22464. Epub 2015 Dec 31.

14.

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M.

J Clin Oncol. 2016 Feb 10;34(5):452-9. doi: 10.1200/JCO.2015.61.4925. Epub 2015 Nov 30.

PMID:
26628466
15.

The procedure outcome of laparoscopic resection for 'small' hepatocellular carcinoma is comparable to vlaparoscopic radiofrequency ablation.

Casaccia M, Santori G, Bottino G, Diviacco P, Negri AD, Moraglia E, Adorno E.

J Minim Access Surg. 2015 Oct-Dec;11(4):231-5. doi: 10.4103/0972-9941.144093.

16.

Diagnostic and therapeutic management of hepatocellular carcinoma.

Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G.

World J Gastroenterol. 2015 Nov 14;21(42):12003-21. doi: 10.3748/wjg.v21.i42.12003. Review.

17.

Locoregional treatment for hepatocellular carcinoma: The best is yet to come.

Kalra N, Gupta P, Chawla Y, Khandelwal N.

World J Radiol. 2015 Oct 28;7(10):306-18. doi: 10.4329/wjr.v7.i10.306.

18.

Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma.

Hong YJ, Kim SH, Choi GH, Kim KS, Choi JS.

Korean J Hepatobiliary Pancreat Surg. 2011 Nov;15(4):199-205. doi: 10.14701/kjhbps.2011.15.4.199. Epub 2011 Dec 15.

19.

Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.

Thein HH, Campitelli MA, Yeung LT, Zaheen A, Yoshida EM, Earle CC.

PLoS One. 2015 Sep 23;10(9):e0138907. doi: 10.1371/journal.pone.0138907. eCollection 2015.

20.

Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.

Thein HH, Khoo E, Campitelli MA, Zaheen A, Yi Q, De P, Earle CC.

CMAJ Open. 2015 Apr 2;3(2):E208-16. doi: 10.9778/cmajo.20140118. eCollection 2015 Apr-Jun. Erratum in: CMAJ Open. 2015 Oct-Dec;3(4):E359.

Items per page

Supplemental Content

Write to the Help Desk